All Access

Health Tech Deals

Standard

Health Tech Deals Thought Bubble

Thought Bubble

Health Tech Deals Alerts

Alert

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

Queue, a prescription kiosk company, has raised $12.6 million in seed funding, CEO Nick Desai tells Axios Pro exclusively.

What's next: The company is planning a Series A in about a year and is open to debt financing to fund manufacturing, Desai says.

Follow the money: AlleyCorp led, joined by Riot Ventures, House Capital, Ubiquity Ventures, Grep Ventures and Banter Capital.

How it works: Resembling vending machines, Queue's kiosks feature cameras for identity verification, scanners to identify a patient's unique QR code, and an interactive touch screen. 

Inside the machine, AI optical sensors identify each pill as it is dispensed into patient-ready bottles. 

The company's platform currently supports 250 prescribed medications, including statins, metformin and blood pressure medication. The kiosks can also dispense some controlled substances like antidepressants.

Zoom in: Queue aims to sell to large retailers. It plans to be live with an unnamed customer by year-end, and expects to have kiosks live in ten sites by the end of 1Q27, Desai says.

The kiosks are connected to pharmacy management software so customers can track delivery in real time.

What they're saying: "We can reduce the footprint of their pharmacy in their store giving them more square feet back to sell other products at higher margins," Desai says.

Queue can also allow retail pharmacies to expand hours, while reducing staff, he says.

Zoom out: Queue joins a growing segment. Last year, Amazon started to deploy similar kiosks in certain One Medical locations.

Meanwhile, companies like Doctronic offer telemedicine via human clinicians and an AI system able to make clinical decisions like refilling medications. 

Last December, Doctronic launched prescription renewal services in Utah, where its AI refills medications directly for patients without a physician intermediary. The company raised $40 million in March.

Other companies in the space include Asteres Inc and Smart RX Systems.

Exclusive: Queue launches prescription kiosks with $12.6M seed

Investors and strategics alike are trying to lower costs, while speeding up and enhancing patient prescription delivery.

Illustration of money pouring into a prescription bottle.  

Queue, a prescription kiosk company, has raised $12.6 million in seed funding, CEO Nick Desai tells Axios Pro exclusively.What&#x27;s next: The company is planning a Series A in about a year and is open to debt financing to fund manufacturing, Desai says.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

transportation

business

c-suite

retail-news

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

salt-lake-city

denver

fort-lauderdale

cincinnati

boulder

kansas-city

austin

chicago

dallas

detroit

atlanta

indianapolis

nashville

nw-arkansas

columbus

hollywood

north-of-cincy

washington-dc

richmond

san-francisco

boston

des-moines

houston

phoenix

miami

philadelphia

seattle

new-orleans

colorado-springs

huntsville

raleigh

san-antonio

twin-cities

pittsburgh

san-diego

tampa-bay

portland

cleveland

arapahoe

douglas

axios-local

axios-pro

axios-live

the-axios-show

Exclusive: Queue launches prescription kiosks with $12.6M seed

What to read next